Premium
HilleVax Inc (HLVX)
NASDAQ
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norov... HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection. Show more
$189.3 million of cash, cash equivalents and marketable securities as of September 30, 2024 The company is exploring the potential for continued development of its norovirus vaccine candidates in...
$245.0 million of cash, cash equivalents and marketable securities as of June 30, 2024 The company is exploring the potential for continued development of its HIL-214 and HIL-216 norovirus...
BOSTON, July 31, 2024 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced a...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.04 | -2 | 2 | 2.036 | 1.86 | 141332 | 1.94478648 | CS |
| 4 | -0.09 | -4.39024390244 | 2.05 | 2.08 | 1.86 | 170383 | 1.94474392 | CS |
| 12 | 0.0599 | 3.1524656597 | 1.9001 | 2.15 | 1.78 | 249037 | 1.95654395 | CS |
| 26 | 0.36 | 22.5 | 1.6 | 2.15 | 1.58 | 260903 | 1.87033775 | CS |
| 52 | -12.73 | -86.6575901974 | 14.69 | 20.22 | 1.55 | 425596 | 3.99335798 | CS |
| 156 | -16.8 | -89.552238806 | 18.76 | 24.42 | 1.55 | 215455 | 7.15140321 | CS |
| 260 | -16.8 | -89.552238806 | 18.76 | 24.42 | 1.55 | 215455 | 7.15140321 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
